| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunovant, Inc. (IMVT) has 8 insiders with recent SEC Form 4 filings, including 21 buys and 0 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.48M | $43.14M | - | |
| Other | 218.0K | $6.38M | - | |
| Other | 199.7K | $5.84M | - | |
| COO | 175.9K | $5.14M | - | |
| Other | 152.2K | $4.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2019 | Wong Roderick | Chief Executive Officer | Buy | 50,000 | $10.20 | $510,125.00 | +6.3% | |
| Dec 6, 2019 | Wong Roderick | Chief Executive Officer | Buy | 400,000 | $10.25 | $4,100,000.00 | +101.3% | |
| Dec 5, 2019 | Wong Roderick | Chief Executive Officer | Buy | 20,000 | $10.15 | $203,000.00 | +5.3% | |
| Dec 4, 2019 | Wong Roderick | Chief Executive Officer | Buy | 20,000 | $10.15 | $203,000.00 | +5.6% | |
| Dec 3, 2019 | Wong Roderick | Chief Executive Officer | Buy | 66,918 | $10.36 | $693,493.10 | +7.1% | |
| Nov 27, 2019 | Wong Roderick | Chief Executive Officer | Buy | 12,000 | $10.49 | $125,863.60 | +1.4% | |
| Nov 22, 2019 | Wong Roderick | Chief Executive Officer | Buy | 46,999 | $10.40 | $488,960.24 | +6.2% | |
| Nov 19, 2019 | Wong Roderick | Chief Executive Officer | Buy | 72,610 | $10.26 | $744,802.40 | +13.8% | |
| Nov 14, 2019 | Wong Roderick | Chief Executive Officer | Buy | 126,000 | $10.17 | $1,281,420.00 | +41.4% | |
| Nov 11, 2019 | Wong Roderick | Chief Executive Officer | Buy | 30,500 | $10.18 | $310,490.00 | +174.3% |